TRANSCENDPRP Trademark

Trademark Overview

On Wednesday, November 23, 2022, a trademark application was filed for TRANSCENDPRP with the United States Patent and Trademark Office. The USPTO has given the TRANSCENDPRP trademark a serial number of 97690410. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, February 18, 2025. This trademark is owned by Transcend Biologics, LLC. The TRANSCENDPRP trademark is filed in the Medical Instrument Products category with the following description:

Blood component separation apparatus for medical purposes
transcendprp

General Information

Serial Number97690410
Word MarkTRANSCENDPRP
Filing DateWednesday, November 23, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements

Description of MarkThe mark consists of the words "transcendPRP" next to a stylized DNA strand.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBlood component separation apparatus for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, December 16, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTranscend Biologics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressThe Colony, TX 75056
Party NameTranscend Biologics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressThe Colony, TX 75056

Trademark Events

Event DateEvent Description
Monday, September 11, 2023NON-FINAL ACTION E-MAILED
Saturday, November 26, 2022NEW APPLICATION ENTERED
Friday, December 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 17, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 5, 2023ASSIGNED TO EXAMINER
Monday, September 11, 2023NON-FINAL ACTION WRITTEN
Monday, September 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 12, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 12, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, December 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 12, 2024SOU EXTENSION 1 GRANTED
Thursday, September 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2024SOU EXTENSION 1 FILED
Tuesday, February 18, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, February 19, 2025SOU EXTENSION 2 GRANTED
Wednesday, February 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 18, 2025SOU EXTENSION 2 FILED
Friday, September 12, 2025TEAS STATEMENT OF USE RECEIVED

Related Keywords

transcendprp medical purposes apparatus separation component blood